Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 8, 2012Fosphenytoin Sodium InjectionPresence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.West-ward Pharmaceutical Corp. · D-1437-2012Class IIITerminatedAug 8, 2012CaziantImpurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.Watson Laboratories Inc · D-1436-2012Class IITerminatedAug 8, 2012Dr. Reddy's Ciprofloxacin TabletsAdulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride...Dr. Reddy's Laboratories, Inc. · D-1435-2012Class IITerminatedAug 8, 2012Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mgAdulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride...Dr. Reddy's Laboratories, Inc. · D-1434-2012Class IITerminatedAug 8, 2012Estradiol Hemihydrate M20 EP/USP PowderCross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.Bayer HealthCare Pharmaceuticals Inc. · D-1433-2012Class IITerminatedAug 8, 2012OFIRMEVPresence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.Cadence Pharmaceuticals · D-1432-2012Class IITerminatedAug 8, 2012Hydrocodone Bitartrate and Acetaminophen Oral SolutionCGMP Deviations: This product is being recalled because expired flavoring was used in the manufacturing of these lots.Mallinckrodt Inc. · D-1431-2012Class IIITerminatedAug 8, 2012Hydrocodone Bitartrate and Acetaminophen Oral SolutionSubpotent (Multiple Ingredient) Drug: Low out of specification assay results for the hydrocodone bitartrate ingredient was found.Mallinckrodt Inc. · D-1430-2012Class ITerminatedAug 8, 2012Argatroban Injection 50 mg per 50mlA complaint was received from a hospital pharmacy on 11/10/11 for crystalline particulates in a single vial from Lot V10194. Additional small visible particles...Eagle Pharmaceuticals Inc. · D-1429-2012Class IITerminatedAug 8, 2012Metformin Hydrochloride TabletsPresence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant...Zydus Pharmaceuticals USA Inc · D-1428-2012Class IIITerminatedAug 1, 2012TizanidineLabeling: Label Mix-Up; Some bottles of Tizanidine 4mg Tablets, had the incorrect manufacturer (Actavis) printed on the label.Stat Rx USA · D-1427-2012Class IIITerminatedAug 1, 2012Erythromycin Topical Solution USPChemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.Fougera Pharmaceuticals, Inc. · D-1426-2012Class IITerminatedAug 1, 2012Dent's Extra Strength Toothache GumSuperpotent; benzocaineGrandpa Brands Co · D-1425-2012Class IIITerminatedJul 25, 2012Midol CompleteLabeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that...Bayer Healthcare, LLC · D-1424-2012Class IIITerminatedJul 25, 2012Midol CompleteLabeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that...Bayer Healthcare, LLC · D-1423-2012Class IIITerminatedJul 25, 2012Ciprofloxacin TabletsLabeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.Pack Pharmaceuticals · D-1422-2012Class IITerminatedJul 25, 2012Epinephrine InjectionPresence of Particulate MatterLuitpold Pharmaceuticals, Inc. · D-1421-2012Class IIITerminatedJul 25, 2012PitocinLabeling: Label Mix-up: Pitocin storage conditions should be labeled, "Store between 20¿ to 25¿C (68¿ to 77¿F)". Pitocin lot 225867 and part of Pitocin lot 231423 were...JHP Pharmaceuticals, LLC · D-1420-2012Class ITerminatedJul 25, 2012Morphine Sulfate InjectionSuperpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mLHospira Inc. · D-1419-2012Class IITerminatedJul 25, 2012Prefera OB One Gel CapsulesLabeling: Presence of Undeclared Color Additive; The product is being recalled because several inactive ingredients were not included in the labeling for this product...Meda Pharmaceuticals Inc. · D-1418-2012Class IIITerminatedJul 25, 2012HYDROXYZINE HYDROCHLORIDE ORAL SOLUTIONImpurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point.Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals · D-1417-2012Class IITerminatedJul 18, 2012Hydrocodone Bitartrate & Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mLImpurities/Degradation Products: exceeded specification at 3 month stability testingVistaPharm, Inc. · D-1416-2012Class IITerminatedJul 18, 2012Kleenex Foam Hand SanitizerMicrobial Contamination of Non-Sterile Products; The affected lots were found to be contaminated with bacterium, Burkholderia cepacia complex.Kimberly-Clark Corporation · D-1415-2012Class IITerminatedJul 18, 2012Kleenex Luxury Foam Hand SanitizerMicrobial Contamination of Non-Sterile Products; The affected lots were found to be contaminated with bacterium, Burkholderia cepacia complex.Kimberly-Clark Corporation · D-1414-2012Class IITerminatedJul 18, 2012DaytranaMiscalibrated/Defective Delivery System; exceeded the specification for both mechanical peel force (MPF) and/or the z-statistic valueNoven Pharmaceuticals, Inc. · D-1413-2012Class IITerminatedJul 18, 2012TrizivirAdulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.GlaxoSmithKline Inc · D-1412-2012Class IIITerminatedJul 18, 2012HYDROCORTISONE and ACETIC ACID OTIC SOLUTIONImpurities/Degradation Products: Out of specificiation results for impurities at the 18-month room temperature time point.Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals · D-1411-2012Class IIITerminatedJul 18, 2012Nexium (esomeprazole magnesium) Delayed-Release CapsulesAdulterated Presence of Foreign Tablets/Capsules: Some bottles may contain a small number of Nexium 20 mg capsules intended for the Japanese market in addtion to Nexium...ASTRA ZENECA Lp · D-1410-2012Class IITerminatedJul 11, 2012Metoprolol Tartrate Tablets USP 50 mgTablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)Teva Pharmaceuticals USA, Inc. · D-1409-2012Class IITerminatedJul 11, 2012EloxatinCGMP Deviations: Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues...sanofi-aventis US, Inc. · D-1408-2012Class IITerminatedJul 11, 2012EloxatinCGMP Deviations: Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues...sanofi-aventis US, Inc. · D-1407-2012Class IIITerminatedJul 11, 2012Super Colon CleanseLabeling: Label Mix-up: The product is being recalled because active ingredient in the Drug Facts box incorrectly states "Active Ingredients per dose" Senna...Health Plus Incorporated · D-1406-2012Class IIITerminatedJul 11, 2012Balnetar Therapeutic Tar BathSubpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay.Ranbaxy Inc. · D-1405-2012Class IIITerminatedJul 11, 2012Imodium Multi-Symptom Relief CapletsDefective Container; damaged blister unitsMcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. · D-1404-2012Class IIITerminatedJul 11, 2012Loxitane CapsulesLabeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.Watson Laboratories Inc · D-1403-2012Class IIITerminatedJul 11, 2012Loxapine Capsules USPLabeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.Watson Laboratories Inc · D-1402-2012Class IIITerminatedJul 11, 2012Loxapine Capsules USPLabeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.Watson Laboratories Inc · D-1401-2012Class IIITerminatedJul 11, 2012Loxapine Capsules USPLabeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.Watson Laboratories Inc · D-1400-2012Class IIITerminatedJul 11, 2012Loxapine Capsules USPLabeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.Watson Laboratories Inc · D-1399-2012Class IITerminatedJul 4, 2012Nisoldipine Extended Release TabletsFailed USP Dissolution Test Requirements: Out of Specification dissolution result at 18 month time pointShionogi Inc. · D-1398-2012